Analysis of circulating tumor cells in prostate cancer patients at psa recurrence and review of the literature

Salvatore Grisanti, Alessandro Antonelli, Michela Buglione, Camillo Almici, Chiara Foroni, Mario Sodano, Luca Triggiani, Diana Greco, Carlotta Palumbo, Mirella Marini, Stefano M. Magrini, Alfredo Berruti, Claudio Simeone

Risultato della ricerca: Contributo su rivistaArticolo in rivistapeer review

Abstract

Background: Circulating tumor cells have been described in prostate cancer patients at diagnosis and in the metastatic phase but little is known on their role at biochemical PSA recurrence. Patients and Methods: Patients radically cured with either prostatectomy or radiotherapy were sequentially included at PSA recurrence. The presence of CTCs was evaluated by the CellSearch system. Results: Twenty-nine patients were accrued at PSA recurrence. Median PSA at recurrence was 7.2 ng/ml (range=3.86-51.0 ng/ml). The median time to PSA progression was 4.66 years (range=0.1-16 years). CTCs were detected in one patient (3%) with low numbers (1 CTC/7.5 ml). Conclusion: In patients radically cured for prostate cancer at biochemical recurrence, CTCs are detected at very low levels in a minority of patients. Further studies are required to investigate alternative methods of CTC detection and the possible role of the bone marrow pre-metastatic niche at biochemical recurrence.

Lingua originaleInglese
pagine (da-a)2975-2981
Numero di pagine7
RivistaAnticancer Research
Volume36
Numero di pubblicazione6
Stato di pubblicazionePubblicato - giu 2016
Pubblicato esternamente

Fingerprint

Entra nei temi di ricerca di 'Analysis of circulating tumor cells in prostate cancer patients at psa recurrence and review of the literature'. Insieme formano una fingerprint unica.

Cita questo